Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

F H Messerli

Showing results (171-180 of 338) with videos related to

Pageof 34
Sort By:
The American Journal of Cardiology|March 1, 1994
Disparate structural effects on left and right ventricles by angiotensin-converting enzyme inhibitors and calcium antagonists in essential hypertensionD Aristizabal, F H Messerli, E D Frohlich
Archives of Internal Medicine|July 11, 2000
Angiotensin II receptor blockers: equal or preferred substitutes for ACE inhibitors?E Grossman, F H Messerli, J M Neutel
Archives of Internal Medicine|April 29, 1999
Cardiovascular risk factors and physical activity: how much is enough?F H Messerli, R G Ketelhut, K Ketelhut
Journal of Nephrology|November 4, 2000
Diuretic therapy and the risk for renal cell carcinomaR E Schmieder, C Delles, F H Messerli
Hipertension Y Riesgo Vascular|July 17, 2015
Optimal blood pressure targets in 2014 - Does the guideline recommendation match the evidence base?C L Alviar, S Bangalore, F H Messerli
American Heart Journal|August 2, 2001
Desperate diseases, desperate measures: tackling malignant hypertension in the 1950sH O Ventura, M R Mehra, F H Messerli
Hypertension (Dallas, Tex. : 1979)|September 1, 1979
Mitral valve prolapse and borderline hypertensionJ G DeCarvalho, F H Messerli, E D Frohlich
The American Journal of Medicine|October 17, 1983
Pharmacologic and physiologic considerations of adrenoceptor blockadeE D Frohlich, F G Dunn, F H Messerli
Postgraduate Medicine|May 15, 1992
Left ventricular hypertrophy. Its relationship to obesity and hypertensionC J Lavie, H O Ventura, F H Messerli
Drugs|December 1, 1991
Regression of increased left ventricular mass by antihypertensivesC J Lavie, H O Ventura, F H Messerli
Pageof 34

Showing results (171-180 of 338) with videos related to

Sort By:
Pageof 34
The American Journal of Cardiology|March 1, 1994
Disparate structural effects on left and right ventricles by angiotensin-converting enzyme inhibitors and calcium antagonists in essential hypertensionD Aristizabal, F H Messerli, E D Frohlich
Archives of Internal Medicine|July 11, 2000
Angiotensin II receptor blockers: equal or preferred substitutes for ACE inhibitors?E Grossman, F H Messerli, J M Neutel
Archives of Internal Medicine|April 29, 1999
Cardiovascular risk factors and physical activity: how much is enough?F H Messerli, R G Ketelhut, K Ketelhut
Journal of Nephrology|November 4, 2000
Diuretic therapy and the risk for renal cell carcinomaR E Schmieder, C Delles, F H Messerli
Hipertension Y Riesgo Vascular|July 17, 2015
Optimal blood pressure targets in 2014 - Does the guideline recommendation match the evidence base?C L Alviar, S Bangalore, F H Messerli
American Heart Journal|August 2, 2001
Desperate diseases, desperate measures: tackling malignant hypertension in the 1950sH O Ventura, M R Mehra, F H Messerli
Hypertension (Dallas, Tex. : 1979)|September 1, 1979
Mitral valve prolapse and borderline hypertensionJ G DeCarvalho, F H Messerli, E D Frohlich
The American Journal of Medicine|October 17, 1983
Pharmacologic and physiologic considerations of adrenoceptor blockadeE D Frohlich, F G Dunn, F H Messerli
Postgraduate Medicine|May 15, 1992
Left ventricular hypertrophy. Its relationship to obesity and hypertensionC J Lavie, H O Ventura, F H Messerli
Drugs|December 1, 1991
Regression of increased left ventricular mass by antihypertensivesC J Lavie, H O Ventura, F H Messerli
Pageof 34